UT Health San Antonio School of Dentistry awarded $9.8 million NIH grant that could help curb opioid use

January 23, 2023

Study of jaw-joint sensory neurons aimed at creating safer pain treatment The UT Health San Antonio School of Dentistry has received a major five-year, $9.8 million grant from the National Institutes of Health to discover how sensory neurons in the jaw joint and mastication muscles influence and create pain, which could lead to safer drug […]

Increasing brain protein could be a treatment for obesity

January 20, 2023

Drug target that revs up energy expenditure, reduces appetite identified A drug that promotes energy expenditure in the body while suppressing appetite could be a powerful weight loss therapy. Researchers at The University of Texas Health Science Center at San Antonio, the Second Xiangya Hospital of Central South University-China and Baylor College of Medicine reported […]

UT School of Public Health San Antonio inaugural dean receives $1.6 million UT System Faculty STARs award

January 20, 2023

Vasan S. Ramachandran, MD, founding dean of The University of Texas School of Public Health San Antonio, a strategic collaboration between UT Health San Antonio and The University of Texas at San Antonio (UTSA), has received a UT System Faculty Science and Technology Acquisition and Retention (STARs) award for more than $1.6 million to fund […]

A new era in Alzheimer’s treatment

January 11, 2023

Statement from the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio about a timely topic in the news: The U.S. Food and Drug Administration on Friday, Jan. 6, 2023, approved lecanemab, a drug that targets the basic pathophysiology of Alzheimer’s disease. The FDA action is an “accelerated approval” of the […]